HALOZYME THERAPEUTICS INC

CUSIP: 40637HAD1 Class: NOTE 0.250% 3/0

Boussard & Gavaudan Investment Management LLP's Holding History (CIK: 0001614986)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 19,500 Value ($000) $22,383 Avg Close — Range —
Q2 2025
Shares 35,200 Value ($000) $35,171 Avg Close — Range —
Q1 2025
Shares 15,000 Value ($000) $15,874 Avg Close — Range —
Q3 2024
Shares 12,500 Value ($000) $12,557 Avg Close — Range —
Q2 2024
Shares 7,000 Value ($000) $6,665 Avg Close — Range —